PURE Biosciences Inc (PK:PURE)
Business Focus: Household Products
| Sector: Consumer Non-Cyclicals | Industry: Household Products |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 771 Jamacha Road #512 EL CAJON CA 92019 |
| Tel: | 1-619-5968600 |
| Website: | https://www.purebio.com |
| IR: | See website |
| Key People | ||
| Robert Bartlett President, Chief Executive Officer, Director | Tom Richard Myers Executive Vice President - Technology and Development, Director | |
| Business Overview |
| PURE Bioscience, Inc. is focused on developing and commercializing its proprietary antimicrobial products primarily in the food safety arena. The Company provides solutions to combat the health and environmental problems of pathogen and hygienic control. Its technology platform is based on patented, stabilized ionic silver, and its initial products contain silver dihydrogen citrate (SDC). SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. The Company offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies. It also offers PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, products preserved with SDC and SDC as a raw material ingredient for manufacturing use. The Company sells its products directly and indirectly through third-party distributors. |
| Financial Overview |
| For the six months ended 31 January 2024, PURE Biosciences Inc revenues increased 21% to $1M. Net loss decreased 15% to $1.7M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects MISCELLANEOUS CHEMICAL PRODUCTS segment loss decrease of 2% to $964K. Basic Earnings per Share excluding Extraordinary Items remained flat at -$0.02. |
| Employees: | 11 as of Oct 30, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $12.37M as of Jan 31, 2024 |
| Annual revenue (TTM): | $2.06M as of Jan 31, 2024 |
| EBITDA (TTM): | -$3.14M as of Jan 31, 2024 |
| Net annual income (TTM): | -$3.65M as of Jan 31, 2024 |
| Free cash flow (TTM): | -$2.73M as of Jan 31, 2024 |
| Net Debt Last Fiscal Year: | $1.31M as of Jan 31, 2024 |
| Shares outstanding: | 111,856,473 as of Mar 18, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.